Peptide appearance Lyophilized form

Tissue Biology Research

15 000+ verified orders

BPC-157 / TB500

In stock

A two-component BPC-157 and TB-500 research blend with declared component amounts.

Available strengths
129,90 €
Bundle & save
Buy in Bulk 10+ units35% off →

Arrives 5 – 9 November to Europe

We accept Visa Mastercard Apple Pay (when supported) Google Pay (when supported) Shown at checkout

BPC-157 / TB500

Price range: 83,50 € through 129,90 €

BPC-157 and TB-500 blend for paired tissue-signalling and cell-migration studies.

SKU: ADRIA-BPC-157-TB500 Categories: ,

Research overview

BPC-157 / TB500

BPC-157 / TB500 combines two separately described peptide research materials in one vial.

The blend should be interpreted component by component for identity, sequence, and analytical documentation rather than as a new single compound. The listed sources are a research starting point rather than a substitute for product evidence: the supplied material's exact form, lot, and measured characteristics must be established through its signed analytical record.

Compound information

Specifications

Molecular profile

Sequence
BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val; TB-500 (thymosin beta-4): Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH
Molecular mass
BPC-157: 1419.54 g/mol; TB-500 (thymosin beta-4): 4963.49 g/mol
CAS number
BPC-157: 137525-51-0; TB-500 (thymosin beta-4): 77591-33-4
Molecular formula
BPC-157: C62H98N16O22; TB-500 (thymosin beta-4): C212H350N56O78S

Material record

Physical appearance
White to off-white lyophilized powder
Solubility
Soluble in bacteriostatic water and suitable aqueous laboratory solvents.
Product note
Two-component blend containing BPC-157 and full-length thymosin beta-4; supplied strictly for research use only.

Laboratory care

Handling

Peptides in transport

Peptides in lyophilized form are supplied in glass vials by standard shipping methods and do not require refrigeration. Short-term temperature fluctuations during transport will not reduce their quality and efficacy. Even at high summer temperatures, the peptides in lyophilized form are stable for several weeks.

Storage of lyophilized peptides

Lyophilized peptides should be stored in a dry place, protected from light and moisture. The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Up to 3 months
  • Refrigerated (2–8 °C): Up to 6 months
  • Frozen (-20 °C or below): 3–5 years (recommended for long-term storage)

Allow the vial to reach room temperature after taking it out of the refrigerator or freezer.

Storage of reconstituted peptides

Once reconstituted, peptide solutions are generally less stable than their lyophilized form and should be stored under refrigerated conditions whenever possible.

The following storage conditions are generally recommended:

  • Room temperature (15–25 °C): Avoid prolonged storage
  • Refrigerated (2–8 °C): Typically 4–8 weeks
  • Frozen (-20 °C or below): Up to 3–4 months

To preserve peptide integrity, avoid repeated freeze–thaw cycles, as these may accelerate peptide degradation.

Important: Most manufacturers recommend discarding reconstituted peptides within 4 weeks when stored at 2–8 °C. This recommendation is intentionally conservative and may not reflect the actual chemical stability of every peptide. In our own stability studies, many peptides reconstituted in bacteriostatic water showed no detectable degradation after 12 weeks of refrigerated storage. As peptide stability is highly sequence- and formulation-dependent, this result should not be extrapolated to all peptides without supporting stability data.

Analytical documentation

Tests

Latest published result

Liquilabs s.r.o.Signed Certificate of Analysis · 10mg + 10mg

Certificate preview for 10mg + 10mg

See reportPurity by HPLC

Batch number
2767156
Tested
2026-09-08

Recorded QC panel

BPC-157 assayPeptide Screening 0.1% TFA
12.79 mg (± 0.06 mg)
TB-500 assayPeptide Screening 0.1% TFA
12.31 mg (± 0.06 mg)
BPC-157 purityPeptide Screening 0.1% TFA
99.6%
TB-500 purityPeptide Screening 0.1% TFA
99.3%
BPC-157 identity (RT)Retention time
0.998 (± 0.005)
TB-500 identity (RT)Retention time
0.993 (± 0.005)
Bacterial endotoxinUSP 85 / Eur. Ph. 2.6.14
0.026 EU/mg
BPC-157 molecular ion massMass Spectrometry Identity
1419 Da (± 1 Da)
TB-500 molecular ion massMass Spectrometry Identity
4963 Da (± 1 Da)

These are the latest published results for this strength. The batch number is printed on each vial. Your supplied batch is confirmed against the matching published record when your order is allocated.

See all test results

Signed certificate

Source record

References

National Center for Biotechnology Information

PubChem Compound Summary: BPC-157

Identity record for the BPC-157 component.

PubChem · View source ↗

National Center for Biotechnology Information

PubChem Compound Summary: Thymosin beta 4

Identity record for the thymosin-beta-4-related TB-500 component.

PubChem · View source ↗

Chemical Abstracts Service

CAS Common Chemistry: 137525-51-0

Authoritative CAS Registry Number record for the BPC-157 component.

CAS Common Chemistry · View source ↗

National Center for Biotechnology Information

PubChem compound record

PubChem · View source ↗

Goldstein AL, Hannappel E, Sosne G, Kleinman HK · 2012

Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

Expert opinion on biological therapy · View source ↗

Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM · 2025

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review

HSS journal : the musculoskeletal journal of Hospital for Special Surgery · View source ↗

Ruff D, Crockford D, Girardi G, Zhang Y · 2010

A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers

Annals of the New York Academy of Sciences · View source ↗

Malinda KM, Sidhu GS, Mani H, Banaudha K, Maheshwari RK, Goldstein AL, Kleinman HK · 1999

Thymosin beta4 accelerates wound healing

The Journal of investigative dermatology · View source ↗

Xu C, Sun L, Ren F, Huang P, Tian Z, Cui J, Zhang W, Wang S, Zhang K, He L, Zhang W, Zhang C, Hao Q, Zhang Y, Li M, Li W · 2020

Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds

Regulatory toxicology and pharmacology : RTP · View source ↗

Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D · 2004

Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair

Nature · View source ↗

· 2018

BPC-157 enhances growth hormone receptor expression in injured tendon tissueStaresinic M, Sebecic B, et al

Growth Hormone & IGF Research · View source ↗

Xing Y, Ye Y, Zuo H, Li Y · 2021

Progress on the Function and Application of Thymosin β4

Frontiers in endocrinology · View source ↗

Customer reviews

4.6/5100+ reviews
View on Trustpilot ↗Checked 7 Oct 2026

had a communication issue with my order at first and was worried about the delay. The team got back to me and the problem was resolved. I'm satisfied with the products and happy with how it turned out in the end. Thank you for sorting it out.

Read full review →

Personale cordiale è sempre disponibile, veloci nella consegna Peccato che non c'è la possibilità di pagare con la carta

Read full review →

Häirib see, et iga uue tellimuse juures on jälle uus pangakonto number, mida ma pean käsitsi igakord uuesti sisestama.

Read full review →